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Edited by Hans EklundAbstract The catalytic activity of selenocysteine-containing
thioredoxin reductases can be mimicked by cysteine-variants if
the local environment at the C-terminal redox center supports
thiol activation. This concept of a linear catalytic site was chal-
lenged by structural data suggesting that the invariant residue
His106 functions as a base catalyst for the dithiol-disulphide ex-
change reaction between enzyme and substrate. As reported here,
we changed His106 to asparagine, glutamine, and phenylalanine
in various C-terminal mutants of Drosophila melanogaster thio-
redoxin reductase. The catalytic activity dropped considerably,
yet pH-proﬁles did not reveal diﬀerences, rendering a function
for His106 as a base catalyst unlikely. Interestingly, the phenyl-
alanine-mutants, designed as negative controls were the most ac-
tive mutants which suggests rather a structural role of His106.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The thioredoxin system – formed by thioredoxin reductase
(TrxR; EC 1.8.1.9 1), NADPH and its naming substrate thio-
redoxin (Trx) – is an important constituent of the intracellular
redox milieu. It interacts with many diﬀerent metabolic path-
ways such as DNA-synthesis, selenium metabolism and the
antioxidative network, and it exhibits signiﬁcant species diﬀer-
ences. This renders the system an attractive and currently
extensively studied chemotherapeutic target in many ﬁelds of
medicine – ranging from infectious diseases to cancer therapy
(see Ref. [1] for review).
TrxR (thioredoxin-S2 + NADPH + H
+  thioredoxin-
(SH)2 + NADP
+) is an NADPH-dependent ﬂavoenzyme
belonging to a family of homodimeric pyridine nucleotide-
disulphide oxidoreductases which includes enzymes like gluta-
thione reductase, lipoamide dehydrogenase, trypanothione
reductase, and mercuric ion reductase [2]. Two distinct classesAbbreviations: Dm, Drosophila melanogaster; Sec, selenocysteine;
(Dm)Trx, (Drosophila melanogaster) thioredoxin; (Dm)TrxR, (Dro-
sophila melanogaster) thioredoxin reductase; -SCCS, -SCCG, -GCCS
and -GCCG, indicate the respective sequence of the C-terminal
tetrapeptide of Dm TrxR in one letter code; DTNB, 5,5 0-dithio-bis-
(2-nitrobenzoic acid)
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1 Thioredoxin reductase was formerly designated 1.6.4.5.
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prox. 35 kDa) primarily present in bacteria, fungi, and plants
and large TrxRs (subunit Mr approx. 55 kDa) present e.g. in
higher eukaryotes. They diﬀer in many aspects, such as the
substrate spectrum, which is far broader for large than for
small TrxRs [1].
A key feature of the proposed mechanism of large thiore-
doxin reductases is the relatively ﬂexible C-terminal tail which
is responsible for the transport of electrons from the buried N-
terminal redox-center near the ﬂavin to bulky substrates at the
surface. This requires a second redox-active site located on the
C-terminal tail [3–5].
The particular design of the second redox-center present in
large thioredoxin reductases diﬀers between species: In mam-
malian TrxRs it is formed by a sequentially directly adjacent
cysteine–selenocysteine-pair, whereas in the enzyme of Diptera
two cysteines form this motif [6,7]. Astonishingly, these cys-
teine-variants are almost as active as their selenocysteine coun-
terparts, despite the signiﬁcantly higher pKa of cysteines and
thus a reduced tendency to form the anions required for disul-
phide exchange reactions. Recent experiments strongly suggest
that indeed sequentially neighbouring residues activate the thi-
ols [8]: In Drosophila melanogaster TrxR (containing the ﬂexi-
ble terminal sequence SCCS) hydroxyl groups of the ﬂanking
serines form hydrogen bonds with the thiols, lowering their
pKa and thus increase reactivity.
It was, however, also suggested that a base catalyst facili-
tates the reaction between enzyme and substrate – with the
highly conserved His106, 2 located in close proximity to the
C-terminal Cys–Cys-pair [9], being the prime candidate (Fig.
1A and B). This function of His106 was postulated in analogy
to His464 which catalyzes the intramolecular dithiol-disulphide
exchange between two cysteine pairs within the dimeric en-
zyme (Fig. 1A and B, [10–13] and own observations, unpub-
lished).
The objective of this work was to verify this hypothesis and
thus provide further insight into the mechanistic details of
large thioredoxin reductases – a prerequisite for a rational,
mechanism-based drug design.2. Materials and methods
Cloning, expression and puriﬁcation of the 15 DmTrxR-1 mutants
and wild-type enzyme were performed applying established proce-
dures, as were enzyme kinetics (KM, kcat), pH-activity proﬁles, circular2 The numbering of residues in the text refers to Drosophila melano-
gaster TrxR-1 (AF301144).
blished by Elsevier B.V. All rights reserved.
Fig. 1. (A) Partial sequence alignment of large TrxRs and glutathione reductases. The conserved residues His106 (red) and His464
0
(blue) are highlighted.
Alignments were done using the online-tool Clustal W 1.82 (www.ebi.ac.uk/clustalw). hTrxR-1 = human TrxR-1 (NCBI accession number: s66677),
hTrxR-2 = human TrxR-2 (aad51324), SsTrxR = pig TrxR (aaf78791.1), mTrxR = mouse TrxR-1 (np056577), CeTrxR = C. elegans TrxR
(aad41826), AgTrxR = Anopheles gambiae TrxR (cad30858), DmTrxR-1 = D. melanogaster TrxR-1 (aag25640), hGR = human glutathione reductase
(rdhuu) (B) 3D-model of His106 (red) and His464
0
(blue) in D. melanogaster TrxR based on the structural information provided by protein data base
(www.rcsb.org) ﬁle 1H6V of a Sec498ﬁ Cys rat TrxR mutant (subunits E and F) [9]. The C-terminal tail of one subunit is shown in green, with the
adjacent cysteines highlighted in yellow. The second subunit, containing His106, is shown in dark gray. Also highlighted in yellow are the N-terminal
cysteines and FAD (orange). The structure shown here was created using H. J. Bernsteins RasMol V 2.7.2.1.1 (www.bernstein-plus-sons.com/
software/rasmol). (C) Structural side-chain comparison of histidine and the amino acids used in the mutants of His106: glutamine, asparagine and
phenylalanine.
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found in this articles online supplement, which is available at the
FEBS-Letters homepage. The enzyme species are designated according
to their C-terminal tetrapeptide sequence (Gly–Cys–Cys–Gly =
GCCG, Gly–Cys–Cys–Ser = GCCS, Ser–Cys–Cys–Gly = SCCG and
Ser–Cys–Cys–Ser = SCCS = wild-type (wt)), and, furthermore, accord-
ing to the respective mutation at position 106.3 DmTrxR, as well as Plasmodium falciparum and Anopheles gambiae
TrxR are rapidly inactivated at higher concentrations of DTNB. This
leads to the higher standard deviation values as indicated by the error
bars in Fig. 2B compared to Fig. 2A.3. Results and discussion
The catalytic reactions on the Si-side of the ﬂavin in large
thioredoxin reductases are essentially dithiol-disulphide ex-
change reactions. In the course of these reactions a more reac-
tive intermediate, a thiolate or selenolate, has to be formed at
the C-terminal redox center of thioredoxin reductase [1,14].
The question, why the catalytic activity of cysteine containing
TrxRs, such as those from D. melanogaster or Anopheles gam-
biae, almost matches that of their selenocysteine counterpart
was addressed recently [8]. The hydroxyl groups of residues
sequentially adjacent to the redox-active C-terminal Cys–
Cys-pair seem to lower the thiols’ pKa, facilitating thiolate
formation.
We changed His106 to asparagine, glutamine, and phenylal-
anine, respectively. All three amino acids share some structural
features with histidine (Fig. 1C), however, they are either no
(Phe) or poorer potential base catalysts (Asn, Gln) than His
[15]. Asparagine and glutamine were chosen, as relative phylo-
genetic substitution frequencies indicate, that histidine is more
likely substituted for glutamine (ratio 1.2) or asparagine (ratio
1.3) than for glutamate (ratio 0.8) or aspartate (ratio 0.9); the
ratio for His  Phe is 0.7 [16].
We obtained pure, yellow-colored, enzymatically active pro-
teins for wild-type and all 15 mutants of His106. A number of
mutants were cloned twice independently with reproducible ki-netic results (KM- and kcat-values diﬀered by less than ±5%).
Neither the absorbance-spectra (which showed typical ﬂavo-
protein characteristics) nor the circular dichroism spectra re-
vealed any signiﬁcant diﬀerences between the mutants and
wild-type enzyme, indicating an identical overall structure. If
His106 indeed acted as an important base catalyst, one would
expect a signiﬁcant drop in activity for all three mutants, with
the highest loss of activity for the phenylalanine mutant. This
was, however, not the case: Even though all three mutants
were less active in thioredoxin reduction (kcat) than the His-
containing wild-type enzyme (Fig. 2A), the phenylalanine mu-
tants, originally designed as negative controls, were the most
active ones (Fig. 2). The KM-values for thioredoxin remained
essentially unaltered (Fig. 2A), indicating that the formation
of the Michaelis-complex is not aﬀected. Moreover, no shift
in the pH-proﬁle (not shown, pH-optima at around 7.5–8.0)
was observed for any of the mutants [8].
The exchange of the polar serines for glycines led to a signif-
icant loss of activity. Thus these glycine-mutants should be
even more sensitive to an exchange of His106 for Asn, Gln or
even Phe if histidine106 acted as a base catalyst. Yet, this was
not the case either.
In order to investigate the possibility that His106 might serve
as a base catalyst for substrates other than thioredoxin we also
analyzed DTNB (5,5 0-Dithio-bis-(2-nitrobenzoic acid)), a low
molecular weight compound [17], with the SCCS mutant series
(Fig. 2B 3). In this case the asparagine and glutamine mutant
showed 15–20% reduced activities compared to the wild-type
A B
Fig. 2. (A) Kinetic parameters of mutagenized DmTrxR species using thioredoxin as a substrate. The bottom line of the Figure shows various C-
terminal linear catalytic sites, the wild-type SCCS in the left panel and 3 mutants thereof in the other panels. The line above indicates varying amino
acids at position 106 for each panel, His106 representing the wild-type. Dark vertical columns show the kcat-values and white columns the KM-values
(Dm Trx-2, GHOST-assay). Error bars indicate ± SD. (B) Kinetic parameters of mutagenized DmTrxR species using 5,5 0-Dithio-bis-(2-nitrobenzoic
acid) as a substrate. The symbols are as in (A). Only the catalytic site mutant Dm TrxR-SCCS with diﬀerent residues at position 106 (His, Asn, Gln,
Phe) is shown.
J. Jacob et al. / FEBS Letters 579 (2005) 745–748 747enzyme, whereas the phenylalanine mutant did not show a de-
crease in activity at all.
Taken together, these data show that His106 does not serve
as an important, if at all, base catalyst in large TrxRs. How-
ever, the fact that all substitutions at position 106 led to a
signiﬁcant decrease in (TrxS2-)reduction activity, indicates
that the highly conserved His106 is indeed of importance
for large thioredoxin reductases. As acid–base functionality
apparently plays a subordinate role, the highest degree of
deviation from the imidazoles structure is present in aspar-
agine and glutamine, whereas the aromatic ring of phenylal-
anine is sterically most closely related to His (Fig. 1C). This
view is reﬂected by the obtained kinetic data (Fig. 2A and
B). The overall structure of the enzymes – as judged by
KM-determination, absorbance- and CD-spectrometry – re-
mained unaltered, yet, obviously the local structural environ-
ment has changed. Cavity creation, as occasionally observed
with alanine mutation [18], is a possible, yet not very likely
explanation for the diﬀerences between the mutants, as
asparagine is larger and more rigid and glutamine, even
though more ﬂexible, is much bulkier than alanine (Fig.
1C) [16].
From the data provided by the rat mutant enzyme struc-
ture [9], His106 ﬁts well into a grove formed by a hydropho-
bic and a hydrophilic circle in the enzyme structure. As the
currently available structural data of large TrxRs still leave
room for interpretations, it is diﬃcult to predict which struc-
tural interactions and features render His106 so important,
particularly as the C-terminal tail is very ﬂexible and thus
diﬃcult to study by x-ray diﬀraction analysis [19]. However,
our data strongly suggest that it is indeed primarily a struc-
tural feature that has led to the conservation of His106. This
is in line with recent reports suggesting that histidine might
serve more frequently as a structural component of proteins
than previously thought [20].
Now that His106 has basically been dropped from the list of
candidates for a base catalyst in large TrxR, two options re-
main: Either there is no real base catalyst, or other residues
or helix-dipoles are committed to that task. The notion that in-
deed no base catalyst is involved in the intermolecular dithiol-
disulphide exchange reaction between enzyme and substrate issupported by the ﬁnding that Cys490ﬁ Sec mutants of
DmTrxR exhibit kcat-values essentially identical to those of
wild-type (SCCS) enzyme [8].
From a more general biochemical point of view, it is note-
worthy that the substitution Hisﬁ Phe should probably be
used more frequently in mutational studies. Our results indi-
cate that other negative control substitutes, such as the com-
monly used alanine, might lead to misinterpretation, as
histidine may be underestimated as a structural component un-
der these conditions.
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